Mary K Wolpert-Defilippes

Title: Mary K. Wolpert-Defilippes: Innovator in Antineoplastic Research

Introduction

Mary K. Wolpert-Defilippes is a notable inventor based in Bethesda, MD, USA, recognized for her contributions to the field of medicine, particularly in the development of antineoplastic agents. Her innovative work has the potential to impact cancer treatment significantly.

Latest Patents

Mary K. Wolpert-Defilippes holds one patent for her invention titled "Antineoplastic platinum (IV) complexes and compositions." This patent reveals the creation of new substantially isomerically pure tetrahalo (1,2-diaminocyclohexane) Pt (IV) complexes that demonstrate antineoplastic activity. This development represents a significant advancement in the search for effective cancer therapies.

Career Highlights

Wolpert-Defilippes' career is prominently marked by her role at the United States of America as Represented by the Department of Health. Here, she has made substantial contributions to the research and development of new medicinal compounds. Her work has helped pave the way for advancements in treating various types of cancers.

Collaborations

Throughout her career, Mary has collaborated with notable peers in her field, including Venkatachala L. Narayanan and Rudiger D. Haugwitz. These collaborations underscore the importance of teamwork in innovation and highlight the interdisciplinary nature of her research.

Conclusion

Mary K. Wolpert-Defilippes exemplifies the spirit of innovation in her field through her ongoing research and patent contributions. Her work not only enhances scientific understanding of antineoplastic compounds but also brings hope for improved treatment options for cancer patients.